Showing results (41-50 of 125) with videos related to
Sort By:
Pageof 13
Nederlands Tijdschrift Voor Geneeskunde|October 17, 2003
[Androgens, well-being and libido in women]E J van Santbrink, W L Gianotten, B C FauserFertility and Sterility|February 11, 1998
Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study GroupH J Coelingh Bennink, B C Fauser, H J OutAndrologia|March 1, 1985
Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal responseB C Fauser, R Rolland, J M Dony, et al.Fertility and Sterility|May 1, 1983
The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal menB C Fauser, J M Dony, W H Doesburg, et al.Maturitas|May 10, 2000
Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal womenB Berning, C van Kuijk, H J Bennink, et al.Journal of Steroid Biochemistry|October 1, 1989
Granulosa cell aromatase bioassay: changes of bioactive FSH levels in the femaleB C Fauser, D Soto, N M Czekala, et al.Fertility and Sterility|January 13, 2000
Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of cultureG J Huisman, B C Fauser, M J Eijkemans, et al.Human Reproduction (Oxford, England)|September 28, 2002
Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogenK Gemzell-Danielsson, A M van Heusden, S R Killick, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndromeI Schipper, F F Rommerts, P M Ten Hacken, et al.Radiology|May 1, 1992
How to discriminate between normal and polycystic ovaries: transvaginal US studyT D Pache, J W Wladimiroff, W C Hop, et al.Pageof 13